JAYTHARI 36 MG Oral Tablet
- RxCUI
- 2716708
- RxNorm name
- JAYTHARI 36 MG Oral Tablet
- Display name
- JAYTHARI 36 MG Oral Tablet
- Full name
- JAYTHARI 36 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JAYTHARI | DEFLAZACORT | Doppel Farmaceutici S.r.l. | 3542a1e3-acfd-6b9a-e063-6394a90a9466 | 2026-08-27 | Warnings, Adverse reactions | 2716708 |
| JAYTHARI | DEFLAZACORT | Zydus Pharmaceuticals (USA) Inc. | ced839ee-1131-45c6-9e38-cc81d85daf1c | 2026-07-23 | Warnings, Adverse reactions | 2716708 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ced839ee-1131-45c6-9e38-cc81d85daf1c | JAYTHARI 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [Jaythari] [SBD] · Jaythari 36 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI JAYTHARI (deflazacort) tablets, for oral use Initial U.S. Approval:2017 | 20250519 |